Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-636-9 | CAS number: 108-99-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Dose descriptor:
- NOAEL
- 50 mg/kg bw/day
Additional information
Pyridine was investigated in an OECD 421 reproductive toxicity study using oral gavage as the route of administration of doses of 12, 25 and 50 mg/kg bw/d in rats. Generalized toxicity was observed at all doses, as noted by mild elevations in liver weights. There were no adverse effects on epididymides and testes of the males, nor in ovaries or uterus in the females, nor were there obvious effects of treatment on mating performance, fertility or duration of gestation. The NOAEL was > 50 mg/kg bw/d, the highest dose tested. This study indicates that there is no adverse reproductive toxicity at doses several-fold higher than doses causing generalized toxicity in the adults.
Short description of key information:
A category of pyridine and methyl pyridine derivatives is comprised
of: pyridine, 2-methylpyridine, 3-methylpyridine and 4-methylpyridine.
The basis of the category is structural similarity (based on the
pyridine unsaturated ring structure) and similar physical properties,
environmental fate and ecotoxicity, and mammalian toxicity. Similar
toxicological properties derive from similar physical-chemical
properties and common pathways of metabolism and elimination among all
members of the category. This category is accepted by the U.S.
Environmental Protection Agency (EPA). In an OECD 421 Reproductive
Toxicity test on pyridine, no reproductive effects were observed at the
highest dose tested. This is supported by data from chronic studies of
pyridine, where no (nontumor ) pathology was observed in reproductive
organs.
Effects on developmental toxicity
Description of key information
A developmental toxicity study (OECD 421) was undertaken on pyridine at doses of 0, 12, 25 and 50 mg/kg bw/d in CD rats. No NOAEL was established due to increased liver weights in all exposed groups. Fewer pups survived to day 4 of lactation in the 50 mg/kg bw/d group. No teratogenic effects were noted. The NOAEL for developmental toxicity was 25 mg/kg bw/d, several fold higher than doses causing toxicity in the dams or adult males.
Effect on developmental toxicity: via oral route
- Dose descriptor:
- NOAEL
- 25 mg/kg bw/day
Additional information
A developmental toxicity study (OECD 421) was undertaken on pyridine, a member of the pyridine derivatives category. Doses of 0, 12, 25 and 50 mg/kg bw/d were administered by oral gavage to male rats at doses for 2 weeks prior to mating, and to females for 2 weeks prior to mating and throughout the gestation and lactation periods. There were no adverse developmental findings attributable to pyridine. Under the conditions of this study, a parental No Observed Effect Level (NOAEL) was not established (< 12 mg/kg bw/d) due to the increased liver weights observed in all treatment groups. The NOEL for developmental parameters was considered to be 25 mg/kg bw/day based on decreased mean numbers of live pups per litter on days 1 and 4 of lactation for the 50 mg/kg bw/day dose group. This study indicates that there is no adverse developmental toxicity at doses several-fold higher than doses causing toxicity in adult animals.
Justification for classification or non-classification
Pyridine, a structural analogue to 3 -methylpyridine based on a chemical category, has been adequately studied in animal protocols, demonstrating no targeted toxicity to the reproductive system except at high doses causing parental toxicity. This substance is not classified as a reproductive toxicant or a CMR (carcinogen, mutagen or reproductive toxicant).
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.